Patents by Inventor Christopher R. Diorio

Christopher R. Diorio has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Bazedoxifene acetate formulations
    Patent number: 7771744
    Abstract: Bazedoxifene acetate formulations and compositions thereof having improved properties relating to reduction, elimination, or prevention of polymorphic conversion of bazedoxifene acetate, and processes for making such formulations and compositions. Components used in the formulations and compositions include a filler/diluent, an optional second filler/diluent, an optional antioxidant, a glidant/disintegrant, and a lubricant.
    Type: Grant
    Filed: August 23, 2006
    Date of Patent: August 10, 2010
    Assignee: Wyeth LLC
    Inventors: Syed M. Shah, Christopher R. Diorio, Eric C. Ehrnsperger, Kadum A. Ali
  • Sustained-release formulation and uses thereof
    Patent number: 7709024
    Abstract: The present invention provides sustained-release formulations useful and methods for using the same.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: May 4, 2010
    Assignee: Solvay Pharmaceuticals B.V.
    Inventors: Kadum Ali, Christopher R. Diorio, Eric C. Ehrnsperger, Mahdi B. Fawzi, Syed Muzafar Shah
  • Salicylate and gentisate salts of a piperazine compound
    Patent number: 7615551
    Abstract: The present invention provides salt forms, and compositions thereof, useful as modulators of one or more GPCRs and which exhibit desirable characteristics for the same.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: November 10, 2009
    Assignee: Solvay Pharmaceuticals, B.V.
    Inventors: Subodh S. Deshmukh, Kadum Ali, Christopher R. Diorio, Wendy Dulin, Eric C. Ehrnsperger, Mahdi B. Fawzi, Syed Muzafar Shah
  • Glucuronate salt of a piperazine compound
    Patent number: 7595310
    Abstract: The present invention provides a salt form, and compositions thereof, useful as a modulator of one or more GPCRs and which exhibits desirable characteristics for the same. The present invention also provides methods for preparing said salt form.
    Type: Grant
    Filed: September 12, 2006
    Date of Patent: September 29, 2009
    Assignee: Solvay Pharmaceuticals, B.V.
    Inventors: Subodh S. Deshmukh, Kadum Ali, Christopher R. Diorio, Eric C. Ehrnsperger, Mahdi B. Fawzi, Syed Muzafar Shah, Mahmoud Mirmehrabi